Drug Interaction study - assess pharmacokinetics of both AZD5672 and atorvastatin

Exclusion Criteria

• - Any clinically significant disease or disorder which, in the opinion of the investigator, may either put the subject at risk because of participation in the study, or may influence the results of the study, or the subject's ability to participate
• - Known allergy to atorvastatin (or other statins) or previous complications to atorvastatin therapy.
• - Participation in a clinical study involving an investigational product within 5 half-lives of active moieties of the last dose of investigational product or 3 months prior to first dosing (whichever is longer).